MDGL Operating Expenses
Madrigal Pharmaceuticals Inc · Operating Expenses
MDGL Operating Expenses
Latest reported$1.50Bperiod ending
MDGL TTM Operating Expenses (-$50.37M → $1.50B)
TTM operating expenses
High-resolution chart · PNG
MDGL operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 1,497,131,000 | |
| 1,367,517,000 | |
| 1,202,352,000 | |
| 1,012,979,000 | |
| 806,185,000 | |
| 731,785,000 | |
| 671,774,000 | |
| 622,079,000 | |
| 544,286,000 | |
| 454,197,000 | |
| 380,496,000 | |
| 348,619,000 | |
| 330,497,000 | |
| 314,320,000 | |
| 293,571,000 | |
| 272,873,000 | |
| 255,621,000 | |
| 247,090,000 | |
| 242,482,000 | |
| 237,436,000 | |
| 233,062,000 | |
| 221,647,000 | |
| 206,673,000 | |
| 177,072,000 | |
| 142,453,000 | |
| 114,802,000 | |
| 94,888,000 | |
| 79,363,000 | |
| 66,505,000 | |
| 51,631,000 | |
| 40,586,000 | |
| 35,008,000 | |
| 32,327,000 | |
| 32,956,000 | |
| 31,985,000 | |
| 30,816,794 | |
| 36,148,312 | |
| 31,412,312 | |
| 31,784,312 | |
| 34,481,518 | |
| 37,916,000 | |
| 53,725,000 | |
| 67,610,000 | |
| 77,124,000 | |
| 79,179,000 | |
| 81,376,000 | |
| 83,951,000 | |
| 87,501,000 | |
| 89,846,000 | |
| 90,208,000 | |
| 87,559,000 | |
| 81,818,000 | |
| 74,563,000 | |
| 66,634,000 | |
| 61,088,000 | |
| 57,047,000 | |
| 56,390,000 | |
| 55,619,000 | |
| 53,016,000 | |
| 51,756,000 | |
| 51,488,000 | |
| 50,529,000 | |
| 51,701,000 | |
| 50,959,000 | |
| 49,578,000 | |
| 50,277,000 | |
| 63,705,000 | |
| 78,546,000 | |
| 94,036,000 | |
| 103,249,000 | |
| 96,323,000 | |
| 86,165,000 | |
| 73,836,000 | |
| 68,986,000 | |
| 66,215,000 | |
| 62,877,000 | |
| 62,865,000 | |
| 30,471,000 | |
| -1,469,000 | |
| -29,966,000 | |
| -72,034,000 | |
| -83,792,000 | |
| -50,366,000 | |
| -29,249,000 |